1127 related articles for article (PubMed ID: 21795304)
21. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
[TBL] [Abstract][Full Text] [Related]
22. Co-culture of clonal beta cells with GLP-1 and glucagon-secreting cell line impacts on beta cell insulin secretion, proliferation and susceptibility to cytotoxins.
Green AD; Vasu S; Moffett RC; Flatt PR
Biochimie; 2016 Jun; 125():119-25. PubMed ID: 27015674
[TBL] [Abstract][Full Text] [Related]
23. Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells.
McGirr R; Ejbick CE; Carter DE; Andrews JD; Nie Y; Friedman TC; Dhanvantari S
Endocrinology; 2005 Oct; 146(10):4514-23. PubMed ID: 15994347
[TBL] [Abstract][Full Text] [Related]
24. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
Fehmann HC; Habener JF
FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
[TBL] [Abstract][Full Text] [Related]
25. Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets.
Huang C; Yuan L; Cao S
Int J Mol Med; 2015 Jul; 36(1):173-85. PubMed ID: 25976560
[TBL] [Abstract][Full Text] [Related]
26. Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells.
Dhanvantari S; Izzo A; Jansen E; Brubaker PL
Endocrinology; 2001 Jan; 142(1):37-42. PubMed ID: 11145564
[TBL] [Abstract][Full Text] [Related]
27. Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin.
Thyssen S; Arany E; Hill DJ
Endocrinology; 2006 May; 147(5):2346-56. PubMed ID: 16484329
[TBL] [Abstract][Full Text] [Related]
28. Altered proglucagon processing in an alpha-cell line derived from prohormone convertase 2 null mouse islets.
Webb GC; Dey A; Wang J; Stein J; Milewski M; Steiner DF
J Biol Chem; 2004 Jul; 279(30):31068-75. PubMed ID: 15143067
[TBL] [Abstract][Full Text] [Related]
29. Progressive change of intra-islet GLP-1 production during diabetes development.
O'Malley TJ; Fava GE; Zhang Y; Fonseca VA; Wu H
Diabetes Metab Res Rev; 2014 Nov; 30(8):661-8. PubMed ID: 24510483
[TBL] [Abstract][Full Text] [Related]
30. Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration.
Kilimnik G; Kim A; Steiner DF; Friedman TC; Hara M
Islets; 2010; 2(3):149-55. PubMed ID: 20657753
[TBL] [Abstract][Full Text] [Related]
31. Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats.
Yu Y; Wang X; Liu C; Yao D; Hu M; Li J; Hu N; Liu L; Liu X
Toxicol Appl Pharmacol; 2013 Feb; 266(3):375-84. PubMed ID: 23200776
[TBL] [Abstract][Full Text] [Related]
32. Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion.
Bethea M; Bozadjieva-Kramer N; Sandoval DA
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34318874
[TBL] [Abstract][Full Text] [Related]
33. Islet prohormone processing in health and disease.
Chen YC; Taylor AJ; Verchere CB
Diabetes Obes Metab; 2018 Sep; 20 Suppl 2():64-76. PubMed ID: 30230179
[TBL] [Abstract][Full Text] [Related]
34. Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity.
Vasu S; Moffett RC; McClenaghan NH; Flatt PR
Exp Cell Res; 2015 Aug; 336(1):100-8. PubMed ID: 26027945
[TBL] [Abstract][Full Text] [Related]
35. β Cell GLP-1R Signaling Alters α Cell Proglucagon Processing after Vertical Sleeve Gastrectomy in Mice.
Garibay D; Lou J; Lee SA; Zaborska KE; Weissman MH; Sloma E; Donahue L; Miller AD; White AC; Michael MD; Sloop KW; Cummings BP
Cell Rep; 2018 Apr; 23(4):967-973. PubMed ID: 29694904
[TBL] [Abstract][Full Text] [Related]
36. Intra-islet glucagon-like peptide 1.
Fava GE; Dong EW; Wu H
J Diabetes Complications; 2016; 30(8):1651-1658. PubMed ID: 27267264
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
Stamenkovic JA; Andersson LE; Adriaenssens AE; Bagge A; Sharoyko VV; Gribble F; Reimann F; Wollheim CB; Mulder H; Spégel P
Biochem J; 2015 May; 468(1):49-63. PubMed ID: 25731850
[TBL] [Abstract][Full Text] [Related]
38. Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.
Shen XX; Li HL; Pan L; Hong J; Xiao J; Hermansen K; Jeppesen PB; Li GW
Endocr Res; 2012; 37(1):12-24. PubMed ID: 22007944
[TBL] [Abstract][Full Text] [Related]
39. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.
Marchetti P; Lupi R; Bugliani M; Kirkpatrick CL; Sebastiani G; Grieco FA; Del Guerra S; D'Aleo V; Piro S; Marselli L; Boggi U; Filipponi F; Tinti L; Salvini L; Wollheim CB; Purrello F; Dotta F
Diabetologia; 2012 Dec; 55(12):3262-72. PubMed ID: 22965295
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
Kedees MH; Grigoryan M; Guz Y; Teitelman G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
